Oncology
 |
|
12 december 2018 07:00:46 |
| A banner year for immunotherapy and targeted therapy (Nature Clinical Practice Oncology) |
|
Tweet |
| 69 viewsCategory: Oncology |
 The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations (BMC Cancer)Radical shifts in the first-line management of metastatic renal cell carcinoma (Nature Clinical Practice Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
